Skip to Main Content

Paper Details

NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis.
Nat Commun
36
2017
Cancer, Laryngeal cancers, NSD1, NSD1/2, NSD2, SCCHN, Squamous cell carcinomas of the head and neck, laryngeal, laryngeal cancer, laryngeal gene, laryngeal tumors, nonlaryngeal SCCHN, patient, patients
Author NameAffiliation
Suraj PeriFox Chase Cancer Center
Michael SlifkerFox Chase Cancer Center
Theresa GuoJohns Hopkins University School of Medicine
Theresa GuoJohns Hopkins University School of Medicine
Theresa GuoJohns Hopkins University School of Medicine
Theresa GuoJohns Hopkins University School of Medicine
Erica A GolemisFox Chase Cancer Center
  • 1 - 7

Datasets

Release 1.2